The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a major research effort into the potential of metal compounds in cancer therapy. This book provides a discussion of metal compounds in cancer therapy.
The discovery of the anti-tumour activity of cisplatin in 1965, and its subsequent introduction into clinical trials in 1971, was the catalyst for a m...
The discovery of the antitumour activity of cisplatin in 1965 and its subsequent introduction into clinical trials in 1971 was the catalyst for a major international research effort investigating the potential of metal compounds in cancer therapy. Cisplatin now occupies an important place in the armamentarium of the oncologist due to its effectiveness in the treatment of testicular cancer. A second generation analogue, carbo platin, offers reduced toxicity together with therapeutic activity, which gives it a place in the front-line therapy of genitourinary cancers. These and other successes...
The discovery of the antitumour activity of cisplatin in 1965 and its subsequent introduction into clinical trials in 1971 was the catalyst for a majo...
